Global Corneal Endothelial Keratoplasty 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06253648

Publication Date:

June 19, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Corneal Endothelial Keratoplasty market size is predicted to grow from US$ 156 million in 2025 to US$ 453 million in 2031; it is expected to grow at a CAGR of 19.4% from 2025 to 2031.
Endothelial keratoplasty (EK) is a cornea transplant technique that is the preferred way to restore vision when the inner cell layer of the cornea stops working properly from Fuchs鈥� dystrophy, bullous keratopathy, iridocorneal endothelial (ICE) syndrome, or other endothelial disorders. EK selectively replaces only the diseased layer of the cornea, leaving healthy areas intact.
United States market for Corneal Endothelial Keratoplasty is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Corneal Endothelial Keratoplasty is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Corneal Endothelial Keratoplasty is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Corneal Endothelial Keratoplasty players cover Mayo Clinic, Cellusion, LaserVision, Precise Bio, Altomed, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淐orneal Endothelial Keratoplasty Industry Forecast鈥� looks at past sales and reviews total world Corneal Endothelial Keratoplasty sales in 2024, providing a comprehensive analysis by region and market sector of projected Corneal Endothelial Keratoplasty sales for 2025 through 2031. With Corneal Endothelial Keratoplasty sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Corneal Endothelial Keratoplasty industry.
This Insight Report provides a comprehensive analysis of the global Corneal Endothelial Keratoplasty landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Corneal Endothelial Keratoplasty portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Corneal Endothelial Keratoplasty market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Corneal Endothelial Keratoplasty and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Corneal Endothelial Keratoplasty.
This report presents a comprehensive overview, market shares, and growth opportunities of Corneal Endothelial Keratoplasty market by product type, application, key players and key regions and countries.
Segmentation by Type:
Descemet's Stripping Endothelial Keratoplasty (DSEK)
Descemet's Membrane Endothelial Keratosplaty (DMEK)
Segmentation by Application:
Adults
Children
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Mayo Clinic
Cellusion
LaserVision
Precise Bio
Altomed
CorneaGen

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Corneal Endothelial Keratoplasty 麻豆原创 Size (2020-2031)
2.1.2 Corneal Endothelial Keratoplasty 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Corneal Endothelial Keratoplasty by Country/Region (2020, 2024 & 2031)
2.2 Corneal Endothelial Keratoplasty Segment by Type
2.2.1 Descemet's Stripping Endothelial Keratoplasty (DSEK)
2.2.2 Descemet's Membrane Endothelial Keratosplaty (DMEK)
2.3 Corneal Endothelial Keratoplasty 麻豆原创 Size by Type
2.3.1 Corneal Endothelial Keratoplasty 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Corneal Endothelial Keratoplasty 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Corneal Endothelial Keratoplasty Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Corneal Endothelial Keratoplasty 麻豆原创 Size by Application
2.5.1 Corneal Endothelial Keratoplasty 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Corneal Endothelial Keratoplasty 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Corneal Endothelial Keratoplasty 麻豆原创 Size by Player
3.1 Corneal Endothelial Keratoplasty 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Corneal Endothelial Keratoplasty Revenue by Player (2020-2025)
3.1.2 Global Corneal Endothelial Keratoplasty Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Corneal Endothelial Keratoplasty Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Corneal Endothelial Keratoplasty by Region
4.1 Corneal Endothelial Keratoplasty 麻豆原创 Size by Region (2020-2025)
4.2 Global Corneal Endothelial Keratoplasty Annual Revenue by Country/Region (2020-2025)
4.3 Americas Corneal Endothelial Keratoplasty 麻豆原创 Size Growth (2020-2025)
4.4 APAC Corneal Endothelial Keratoplasty 麻豆原创 Size Growth (2020-2025)
4.5 Europe Corneal Endothelial Keratoplasty 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Corneal Endothelial Keratoplasty 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Corneal Endothelial Keratoplasty 麻豆原创 Size by Country (2020-2025)
5.2 Americas Corneal Endothelial Keratoplasty 麻豆原创 Size by Type (2020-2025)
5.3 Americas Corneal Endothelial Keratoplasty 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Corneal Endothelial Keratoplasty 麻豆原创 Size by Region (2020-2025)
6.2 APAC Corneal Endothelial Keratoplasty 麻豆原创 Size by Type (2020-2025)
6.3 APAC Corneal Endothelial Keratoplasty 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Corneal Endothelial Keratoplasty 麻豆原创 Size by Country (2020-2025)
7.2 Europe Corneal Endothelial Keratoplasty 麻豆原创 Size by Type (2020-2025)
7.3 Europe Corneal Endothelial Keratoplasty 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Corneal Endothelial Keratoplasty by Region (2020-2025)
8.2 Middle East & Africa Corneal Endothelial Keratoplasty 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Corneal Endothelial Keratoplasty 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Corneal Endothelial Keratoplasty 麻豆原创 Forecast
10.1 Global Corneal Endothelial Keratoplasty Forecast by Region (2026-2031)
10.1.1 Global Corneal Endothelial Keratoplasty Forecast by Region (2026-2031)
10.1.2 Americas Corneal Endothelial Keratoplasty Forecast
10.1.3 APAC Corneal Endothelial Keratoplasty Forecast
10.1.4 Europe Corneal Endothelial Keratoplasty Forecast
10.1.5 Middle East & Africa Corneal Endothelial Keratoplasty Forecast
10.2 Americas Corneal Endothelial Keratoplasty Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.2.2 Canada 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.2.3 Mexico 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.2.4 Brazil 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.3 APAC Corneal Endothelial Keratoplasty Forecast by Region (2026-2031)
10.3.1 China Corneal Endothelial Keratoplasty 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.3.3 Korea 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.3.4 Southeast Asia 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.3.5 India 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.3.6 Australia 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.4 Europe Corneal Endothelial Keratoplasty Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.4.2 France 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.4.3 UK 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.4.4 Italy 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.4.5 Russia 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.5 Middle East & Africa Corneal Endothelial Keratoplasty Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.5.2 South Africa 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.5.3 Israel 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.5.4 Turkey 麻豆原创 Corneal Endothelial Keratoplasty Forecast
10.6 Global Corneal Endothelial Keratoplasty Forecast by Type (2026-2031)
10.7 Global Corneal Endothelial Keratoplasty Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Corneal Endothelial Keratoplasty Forecast
11 Key Players Analysis
11.1 Mayo Clinic
11.1.1 Mayo Clinic Company Information
11.1.2 Mayo Clinic Corneal Endothelial Keratoplasty Product Offered
11.1.3 Mayo Clinic Corneal Endothelial Keratoplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Mayo Clinic Main Business Overview
11.1.5 Mayo Clinic Latest Developments
11.2 Cellusion
11.2.1 Cellusion Company Information
11.2.2 Cellusion Corneal Endothelial Keratoplasty Product Offered
11.2.3 Cellusion Corneal Endothelial Keratoplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Cellusion Main Business Overview
11.2.5 Cellusion Latest Developments
11.3 LaserVision
11.3.1 LaserVision Company Information
11.3.2 LaserVision Corneal Endothelial Keratoplasty Product Offered
11.3.3 LaserVision Corneal Endothelial Keratoplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 LaserVision Main Business Overview
11.3.5 LaserVision Latest Developments
11.4 Precise Bio
11.4.1 Precise Bio Company Information
11.4.2 Precise Bio Corneal Endothelial Keratoplasty Product Offered
11.4.3 Precise Bio Corneal Endothelial Keratoplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Precise Bio Main Business Overview
11.4.5 Precise Bio Latest Developments
11.5 Altomed
11.5.1 Altomed Company Information
11.5.2 Altomed Corneal Endothelial Keratoplasty Product Offered
11.5.3 Altomed Corneal Endothelial Keratoplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Altomed Main Business Overview
11.5.5 Altomed Latest Developments
11.6 CorneaGen
11.6.1 CorneaGen Company Information
11.6.2 CorneaGen Corneal Endothelial Keratoplasty Product Offered
11.6.3 CorneaGen Corneal Endothelial Keratoplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 CorneaGen Main Business Overview
11.6.5 CorneaGen Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.